{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T00:38:48Z","timestamp":1794530328982,"version":"4.9.1"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,6,26]],"date-time":"2018-06-26T00:00:00Z","timestamp":1529971200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,6,26]],"date-time":"2018-06-26T00:00:00Z","timestamp":1529971200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000050","name":"U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01HL125892"],"award-info":[{"award-number":["R01HL125892"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["F30HL134252"],"award-info":[{"award-number":["F30HL134252"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01HL125892"],"award-info":[{"award-number":["R01HL125892"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["T32GM07205"],"award-info":[{"award-number":["T32GM07205"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["T32GM07205"],"award-info":[{"award-number":["T32GM07205"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["5T32GM007223-43"],"award-info":[{"award-number":["5T32GM007223-43"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Genetic diseases can be diagnosed early during pregnancy, but many monogenic disorders continue to cause considerable neonatal and pediatric morbidity and mortality. Early intervention through intrauterine gene editing, however, could correct the genetic defect, potentially allowing for normal organ development, functional disease improvement, or cure. Here we demonstrate safe intravenous and intra-amniotic administration of polymeric nanoparticles to fetal mouse tissues at selected gestational ages with no effect on survival or postnatal growth. In utero introduction of nanoparticles containing peptide nucleic acids (PNAs) and donor DNAs corrects a disease-causing mutation in the \u03b2-globin gene in a mouse model of human \u03b2-thalassemia, yielding sustained postnatal elevation of blood hemoglobin levels into the normal range, reduced reticulocyte counts, reversal of splenomegaly, and improved survival, with no detected off-target mutations in partially homologous loci. This work may provide the basis for a safe and versatile method of fetal gene editing for human monogenic disorders.<\/jats:p>","DOI":"10.1038\/s41467-018-04894-2","type":"journal-article","created":{"date-parts":[[2018,6,20]],"date-time":"2018-06-20T15:13:51Z","timestamp":1529507631000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":171,"title":["In utero nanoparticle delivery for site-specific genome editing"],"prefix":"10.1038","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2637-8522","authenticated-orcid":false,"given":"Adele S.","family":"Ricciardi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raman","family":"Bahal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8553-7162","authenticated-orcid":false,"given":"James S.","family":"Farrelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elias","family":"Quijano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony H.","family":"Bianchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerie L.","family":"Luks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1953-8452","authenticated-orcid":false,"given":"Rachael","family":"Putman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7476-9822","authenticated-orcid":false,"given":"Francesc","family":"L\u00f3pez-Gir\u00e1ldez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00fcleyman","family":"Co\u015fkun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5448-5865","authenticated-orcid":false,"given":"Eric","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanfeng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Che","family":"Hsieh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danith H.","family":"Ly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David H.","family":"Stitelman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4525-5560","authenticated-orcid":false,"given":"Peter M.","family":"Glazer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. Mark","family":"Saltzman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,6,26]]},"reference":[{"key":"4894_CR1","doi-asserted-by":"publisher","first-page":"480","DOI":"10.2471\/BLT.06.036673","volume":"86","author":"B Modell","year":"2008","unstructured":"Modell, B. & Darlison, M. Global epidemiology of haemoglobin disorders and derived service indicators. Bull. World Health Organ. 86, 480\u2013487 (2008).","journal-title":"Bull. World Health Organ"},{"key":"4894_CR2","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1038\/nature11251","volume":"487","author":"HC Fan","year":"2012","unstructured":"Fan, H. C. et al. Non-invasive prenatal measurement of the fetal genome. Nature 487, 320\u2013324 (2012).","journal-title":"Nature"},{"key":"4894_CR3","doi-asserted-by":"publisher","first-page":"16020","DOI":"10.1038\/mtm.2016.20","volume":"5","author":"G Almeida-Porada","year":"2016","unstructured":"Almeida-Porada, G., Atala, A. & Porada, C. D. In utero stem cell transplantation and gene therapy: rationale, history, and recent advances toward clinical application. Mol. Ther. Methods Clin. Dev. 5, 16020 (2016).","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"4894_CR4","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.bpobgyn.2015.08.006","volume":"31","author":"LE McClain","year":"2016","unstructured":"McClain, L. E. & Flake, A. W. In utero stem cell transplantation and gene therapy: Recent progress and the potential for clinical application. Best. Pract. Res. Clin. Obstet. Gynaecol. 31, 88\u201398 (2016).","journal-title":"Best. Pract. Res. Clin. Obstet. Gynaecol."},{"key":"4894_CR5","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1038\/gt.2012.82","volume":"20","author":"NA McNeer","year":"2013","unstructured":"McNeer, N. A. et al. Systemic delivery of triplex-forming PNA and donor DNA by nanoparticles mediates site-specific genome editing of human hematopoietic cells in vivo. Gene Ther. 20, 658\u2013669 (2013).","journal-title":"Gene Ther."},{"key":"4894_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms13304","volume":"7","author":"R Bahal","year":"2016","unstructured":"Bahal, R. et al. In vivo correction of anaemia in beta-thalassemic mice by gammaPNA-mediated gene editing with nanoparticle delivery. Nat. Commun. 7, 13304 (2016).","journal-title":"Nat. Commun."},{"key":"4894_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms7952","volume":"6","author":"NA McNeer","year":"2015","unstructured":"McNeer, N. A. et al. Nanoparticles that deliver triplex-forming peptide nucleic acid molecules correct F508del CFTR in airway epithelium. Nat. Commun. 6, 6952 (2015).","journal-title":"Nat. Commun."},{"key":"4894_CR8","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1021\/bc00025a001","volume":"5","author":"PE Nielsen","year":"1994","unstructured":"Nielsen, P. E., Egholm, M. & Buchardt, O. Peptide nucleic acid (PNA). A DNA mimic with a peptide backbone. Bioconjug. Chem. 5, 3\u20137 (1994).","journal-title":"Bioconjug. Chem."},{"key":"4894_CR9","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1038\/365566a0","volume":"365","author":"M Egholm","year":"1993","unstructured":"Egholm, M. et al. PNA hybridizes to complementary oligonucleotides obeying the Watson-Crick hydrogen-bonding rules. Nature 365, 566\u2013568 (1993).","journal-title":"Nature"},{"key":"4894_CR10","doi-asserted-by":"publisher","first-page":"16695","DOI":"10.1073\/pnas.262556899","volume":"99","author":"FA Rogers","year":"2002","unstructured":"Rogers, F. A., Vasquez, K. M., Egholm, M. & Glazer, P. M. Site-directed recombination via bifunctional PNA-DNA conjugates. Proc. Natl. Acad. Sci. USA 99, 16695\u201316700 (2002).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"4894_CR11","first-page":"583","volume":"90","author":"E Quijano","year":"2017","unstructured":"Quijano, E., Bahal, R., Ricciardi, A., Saltzman, W. M. & Glazer, P. M. Therapeutic peptide nucleic acids: principles, limitations, and opportunities. Yale J. Biol. Med. 90, 583\u2013598 (2017).","journal-title":"Yale J. Biol. Med."},{"key":"4894_CR12","doi-asserted-by":"publisher","first-page":"632","DOI":"10.3390\/molecules23030632","volume":"23","author":"A Ricciardi","year":"2018","unstructured":"Ricciardi, A. et al. Peptide nucleic acids as a tool for site-specific gene editing. Molecules 23, 632 (2018).","journal-title":"Molecules"},{"key":"4894_CR13","doi-asserted-by":"publisher","first-page":"13514","DOI":"10.1073\/pnas.0711793105","volume":"105","author":"JY Chin","year":"2008","unstructured":"Chin, J. Y. et al. Correction of a splice-site mutation in the beta-globin gene stimulated by triplex-forming peptide nucleic acids. Proc. Natl. Acad. Sci. USA 105, 13514\u201313519 (2008).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"4894_CR14","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1002\/mc.20501","volume":"48","author":"JY Chin","year":"2009","unstructured":"Chin, J. Y. & Glazer, P. M. Repair of DNA lesions associated with triplex-forming oligonucleotides. Mol. Carcinog. 48, 389\u2013399 (2009).","journal-title":"Mol. Carcinog."},{"key":"4894_CR15","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1126\/science.1279811","volume":"258","author":"JC Hanvey","year":"1992","unstructured":"Hanvey, J. C. et al. Antisense and antigene properties of peptide nucleic acids. Science 258, 1481\u20131485 (1992).","journal-title":"Science"},{"key":"4894_CR16","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1017\/S0033583506004148","volume":"38","author":"PE Nielsen","year":"2005","unstructured":"Nielsen, P. E. Addressing the challenges of cellular delivery and bioavailability of peptide nucleic acids (PNA). Q. Rev. Biophys. 38, 345\u2013350 (2005).","journal-title":"Q. Rev. Biophys."},{"key":"4894_CR17","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1038\/mt.2010.200","volume":"19","author":"NA McNeer","year":"2011","unstructured":"McNeer, N. A. et al. Nanoparticles deliver triplex-forming PNAs for site-specific genomic recombination in CD34\u2009+\u2009human hematopoietic progenitors. Mol. Ther. 19, 172\u2013180 (2011).","journal-title":"Mol. Ther."},{"key":"4894_CR18","doi-asserted-by":"publisher","first-page":"e349","DOI":"10.1038\/mtna.2016.58","volume":"5","author":"WJ Dai","year":"2016","unstructured":"Dai, W. J. et al. CRISPR-cas9 for in vivo gene therapy: promise and hurdles. Mol. Ther. Nucleic Acids 5, e349 (2016).","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"4894_CR19","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1089\/hum.2015.069","volume":"26","author":"L Li","year":"2015","unstructured":"Li, L., He, Z. Y., Wei, X. W., Gao, G. P. & Wei, Y. Q. Challenges in CRISPR\/CAS9 delivery: potential roles of nonviral vectors. Hum. Gene Ther. 26, 452\u2013462 (2015).","journal-title":"Hum. Gene Ther."},{"key":"4894_CR20","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1136\/bmj.284.6313.373","volume":"284","author":"J Bang","year":"1982","unstructured":"Bang, J., Bock, J. E. & Trolle, D. Ultrasound-guided fetal intravenous transfusion for severe rhesus haemolytic disease. Br. Med. J. (Clin. Res. Ed.) 284, 373\u2013374 (1982).","journal-title":"Br. Med. J. (Clin. Res. Ed.)"},{"key":"4894_CR21","unstructured":"Moise, K. J. J. Intrauterine fetal transfusion of red cells. UpToDate\u00a0https:\/\/www.uptodate.com\/contents\/intrauterine-fetal-transfusion-of-red-cells (2018)."},{"key":"4894_CR22","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.ajog.2004.06.063","volume":"192","author":"IL Van Kamp","year":"2005","unstructured":"Van Kamp, I. L. et al. Complications of intrauterine intravascular transfusion for fetal anemia due to maternal red-cell alloimmunization. Am. J. Obstet. Gynecol. 192, 171\u2013177 (2005).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"4894_CR23","first-page":"129","volume":"7","author":"SA Pasman","year":"2015","unstructured":"Pasman, S. A. et al. Intrauterine transfusion for fetal anemia due to red blood cell alloimmunization: 14 years experience in Leuven. Facts Views Vis. Obgyn. 7, 129\u2013136 (2015).","journal-title":"Facts Views Vis. Obgyn."},{"key":"4894_CR24","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/S0095-5108(18)30205-7","volume":"23","author":"JA Kitterman","year":"1996","unstructured":"Kitterman, J. A. The effects of mechanical forces on fetal lung growth. Clin. Perinatol. 23, 727\u2013740 (1996).","journal-title":"Clin. Perinatol."},{"key":"4894_CR25","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/0022-4804(86)90189-7","volume":"40","author":"SJ Mulvihill","year":"1986","unstructured":"Mulvihill, S. J., Stone, M. M., Fonkalsrud, E. W. & Debas, H. T. Trophic effect of amniotic fluid on fetal gastrointestinal development. J. Surg. Res. 40, 291\u2013296 (1986).","journal-title":"J. Surg. Res."},{"key":"4894_CR26","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1038\/sj.gt.3300498","volume":"4","author":"AM Douar","year":"1997","unstructured":"Douar, A. M. et al. Foetal gene delivery in mice by intra-amniotic administration of retroviral producer cells and adenovirus. Gene Ther. 4, 883\u2013890 (1997).","journal-title":"Gene Ther."},{"key":"4894_CR27","doi-asserted-by":"publisher","first-page":"e135","DOI":"10.1038\/mtna.2013.59","volume":"2","author":"EB Schleifman","year":"2013","unstructured":"Schleifman, E. B. et al. Site-specific genome editing in PBMCs with PLGA nanoparticle-delivered PNAs confers HIV-1 resistance in humanized mice. Mol. Ther. Nucleic Acids 2, e135 (2013).","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"4894_CR28","doi-asserted-by":"publisher","first-page":"13987","DOI":"10.1021\/bi0351918","volume":"42","author":"T Bentin","year":"2003","unstructured":"Bentin, T., Larsen, H. J. & Nielsen, P. E. Combined triplex\/duplex invasion of double-stranded DNA by \u201ctail-clamp\u201d peptide nucleic acid. Biochemistry 42, 13987\u201313995 (2003).","journal-title":"Biochemistry"},{"key":"4894_CR29","doi-asserted-by":"publisher","first-page":"13996","DOI":"10.1021\/bi035194k","volume":"42","author":"K Kaihatsu","year":"2003","unstructured":"Kaihatsu, K., Shah, R. H., Zhao, X. & Corey, D. R. Extending recognition by peptide nucleic acids (PNAs): binding to duplex DNA and inhibition of transcription by tail-clamp PNA-peptide conjugates. Biochemistry 42, 13996\u201314003 (2003).","journal-title":"Biochemistry"},{"key":"4894_CR30","doi-asserted-by":"publisher","first-page":"5614","DOI":"10.1021\/jo200482d","volume":"76","author":"B Sahu","year":"2011","unstructured":"Sahu, B. et al. Synthesis and characterization of conformationally preorganized, (R)-diethylene glycol-containing gamma-peptide nucleic acids with superior hybridization properties and water solubility. J. Org. Chem. 76, 5614\u20135627 (2011).","journal-title":"J. Org. Chem."},{"key":"4894_CR31","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1002\/cbic.201100646","volume":"13","author":"R Bahal","year":"2012","unstructured":"Bahal, R., Sahu, B., Rapireddy, S., Lee, C. M. & Ly, D. H. Sequence-unrestricted, Watson-Crick recognition of double helical B-DNA by (R)-miniPEG-gammaPNAs. Chembiochem 13, 56\u201360 (2012).","journal-title":"Chembiochem"},{"key":"4894_CR32","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1387\/ijdb.041957mt","volume":"49","author":"M Tavian","year":"2005","unstructured":"Tavian, M. & Peault, B. Embryonic development of the human hematopoietic system. Int. J. Dev. Biol. 49, 243\u2013250 (2005).","journal-title":"Int. J. Dev. Biol."},{"key":"4894_CR33","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.cell.2008.01.025","volume":"132","author":"SH Orkin","year":"2008","unstructured":"Orkin, S. H. & Zon, L. I. Hematopoiesis: an evolving paradigm for stem cell biology. Cell 132, 631\u2013644 (2008).","journal-title":"Cell"},{"key":"4894_CR34","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1038\/ni1560","volume":"9","author":"E Dzierzak","year":"2008","unstructured":"Dzierzak, E. & Speck, N. A. Of lineage and legacy: the development of mammalian hematopoietic stem cells. Nat. Immunol. 9, 129\u2013136 (2008).","journal-title":"Nat. Immunol."},{"key":"4894_CR35","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.1093\/emboj\/19.11.2465","volume":"19","author":"MF de Bruijn","year":"2000","unstructured":"de Bruijn, M. F., Speck, N. A., Peeters, M. C. & Dzierzak, E. Definitive hematopoietic stem cells first develop within the major arterial regions of the mouse embryo. EMBO J. 19, 2465\u20132474 (2000).","journal-title":"EMBO J."},{"key":"4894_CR36","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/j.celrep.2014.09.013","volume":"9","author":"S Coskun","year":"2014","unstructured":"Coskun, S. et al. Development of the fetal bone marrow niche and regulation of HSC quiescence and homing ability by emerging osteolineage cells. Cell Rep. 9, 581\u2013590 (2014).","journal-title":"Cell Rep."},{"key":"4894_CR37","doi-asserted-by":"publisher","first-page":"2808","DOI":"10.1172\/JCI28310","volume":"116","author":"MB Bowie","year":"2006","unstructured":"Bowie, M. B. et al. Hematopoietic stem cells proliferate until after birth and show a reversible phase-specific engraftment defect. J. Clin. Invest. 116, 2808\u20132816 (2006).","journal-title":"J. Clin. Invest."},{"key":"4894_CR38","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1182\/blood.V91.6.2152","volume":"91","author":"J Lewis","year":"1998","unstructured":"Lewis, J. et al. A common human beta globin splicing mutation modeled in mice. Blood 91, 2152\u20132156 (1998).","journal-title":"Blood"},{"key":"4894_CR39","doi-asserted-by":"publisher","first-page":"17413","DOI":"10.1073\/pnas.0909296106","volume":"106","author":"K Chen","year":"2009","unstructured":"Chen, K. et al. Resolving the distinct stages in erythroid differentiation based on dynamic changes in membrane protein expression during erythropoiesis. Proc. Natl. Acad. Sci. USA 106, 17413\u201317418 (2009).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"4894_CR40","doi-asserted-by":"publisher","first-page":"e43","DOI":"10.1182\/blood-2012-09-456079","volume":"121","author":"J Liu","year":"2013","unstructured":"Liu, J. et al. Quantitative analysis of murine terminal erythroid differentiation in vivo: novel method to study normal and disordered erythropoiesis. Blood 121, e43\u2013e49 (2013).","journal-title":"Blood"},{"key":"4894_CR41","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1097\/PAS.0b013e31821247a8","volume":"35","author":"HY Dong","year":"2011","unstructured":"Dong, H. Y., Wilkes, S. & Yang, H. CD71 is selectively and ubiquitously expressed at high levels in erythroid precursors of all maturation stages: a comparative immunochemical study with glycophorin A and hemoglobin A. Am. J. Surg. Pathol. 35, 723\u2013732 (2011).","journal-title":"Am. J. Surg. Pathol."},{"key":"4894_CR42","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1038\/modpathol.2010.194","volume":"24","author":"W Liu","year":"2011","unstructured":"Liu, W. et al. Pure erythroid leukemia: a reassessment of the entity using the 2008 World Health Organization classification. Mod. Pathol. 24, 375\u2013383 (2011).","journal-title":"Mod. Pathol."},{"key":"4894_CR43","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.siny.2009.05.005","volume":"15","author":"JL Roybal","year":"2010","unstructured":"Roybal, J. L., Santore, M. T. & Flake, A. W. Stem cell and genetic therapies for the fetus. Semin. Fetal Neonatal Med. 15, 46\u201351 (2010).","journal-title":"Semin. Fetal Neonatal Med."},{"key":"4894_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms15322","volume":"8","author":"E Song","year":"2017","unstructured":"Song, E. et al. Surface chemistry governs cellular tropism of nanoparticles in the brain. Nat. Commun. 8, 15322 (2017).","journal-title":"Nat. Commun."},{"key":"4894_CR45","doi-asserted-by":"publisher","first-page":"11453","DOI":"10.1073\/pnas.1523141113","volume":"113","author":"Y Deng","year":"2016","unstructured":"Deng, Y. et al. Improved i.p. drug delivery with bioadhesive nanoparticles. Proc. Natl. Acad. Sci. USA 113, 11453\u201311458 (2016).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"4894_CR46","doi-asserted-by":"publisher","first-page":"eaam6764","DOI":"10.1126\/scitranslmed.aam6764","volume":"9","author":"GT Tietjen","year":"2017","unstructured":"Tietjen, G. T. et al. Nanoparticle targeting to the endothelium during normothermic machine perfusion of human kidneys. Sci. Transl. Med. 9, eaam6764 (2017).","journal-title":"Sci. Transl. Med"},{"key":"4894_CR47","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-00297-x","volume":"8","author":"J Cui","year":"2017","unstructured":"Cui, J. et al. Ex vivo pretreatment of human vessels with siRNA nanoparticles provides protein silencing in endothelial cells. Nat. Commun. 8, 191 (2017).","journal-title":"Nat. Commun."},{"key":"4894_CR48","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1242\/dev.109.4.911","volume":"109","author":"A Orr-Urtreger","year":"1990","unstructured":"Orr-Urtreger, A. et al. Developmental expression of c-kit, a proto-oncogene encoded by the W locus. Development 109, 911\u2013923 (1990).","journal-title":"Development"},{"key":"4894_CR49","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1038\/347667a0","volume":"347","author":"Y Matsui","year":"1990","unstructured":"Matsui, Y., Zsebo, K. M. & Hogan, B. L. Embryonic expression of a haematopoietic growth factor encoded by the Sl locus and the ligand for c-kit. Nature 347, 667\u2013669 (1990).","journal-title":"Nature"},{"key":"4894_CR50","doi-asserted-by":"publisher","first-page":"2425","DOI":"10.1002\/j.1460-2075.1991.tb07782.x","volume":"10","author":"E Keshet","year":"1991","unstructured":"Keshet, E. et al. Embryonic RNA expression patterns of the c-kit receptor and its cognate ligand suggest multiple functional roles in mouse development. EMBO J. 10, 2425\u20132435 (1991).","journal-title":"EMBO J."},{"key":"4894_CR51","doi-asserted-by":"publisher","first-page":"e264","DOI":"10.1038\/mtna.2015.37","volume":"4","author":"XH Zhang","year":"2015","unstructured":"Zhang, X. H. et al. Off-target effects in CRISPR\/Cas9-mediated genome engineering. Mol. Ther. Nucleic Acids\u00a04, e264 (2015).","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"4894_CR52","doi-asserted-by":"crossref","unstructured":"Charlesworth, C. et al. Identification of pre-existing adaptive immunity to cas9 proteins in humans. Preprint at https:\/\/www.biorxiv.org\/content\/early\/2018\/01\/05\/243345 (2018).","DOI":"10.1101\/243345"},{"issue":"Suppl 2","key":"4894_CR53","first-page":"75","volume":"7","author":"M Andreani","year":"1991","unstructured":"Andreani, M. et al. Persistence of mixed chimerism in class 3 thalassemic patients following BMT. Bone Marrow Transplant. 7(Suppl 2), 75 (1991).","journal-title":"Bone Marrow Transplant."},{"key":"4894_CR54","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1038\/sj.bmt.1702151","volume":"25","author":"M Andreani","year":"2000","unstructured":"Andreani, M. et al. Long-term survival of ex-thalassemic patients with persistent mixed chimerism after bone marrow transplantation. Bone Marrow Transplant. 25, 401\u2013404 (2000).","journal-title":"Bone Marrow Transplant."},{"key":"4894_CR55","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1038\/sj.mt.6300204","volume":"15","author":"H Felfly","year":"2007","unstructured":"Felfly, H. & Trudel, M. Long-term correction of beta-thalassemia with minimal cellular requirement and transplantation modalities. Mol. Ther. 15, 1701\u20131709 (2007).","journal-title":"Mol. Ther."},{"key":"4894_CR56","doi-asserted-by":"publisher","first-page":"10547","DOI":"10.1073\/pnas.0711666105","volume":"105","author":"A Miccio","year":"2008","unstructured":"Miccio, A. et al. In vivo selection of genetically modified erythroblastic progenitors leads to long-term correction of beta-thalassemia. Proc. Natl. Acad. Sci. USA 105, 10547\u201310552 (2008).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"4894_CR57","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/1056-8727(94)00041-L","volume":"9","author":"S Sayinalp","year":"1995","unstructured":"Sayinalp, S., Sozen, T., Usman, A. & Dundar, S. Investigation of the effect of poorly controlled diabetes mellitus on erythrocyte life. J. Diabetes Complicat. 9, 190\u2013193 (1995).","journal-title":"J. Diabetes Complicat."},{"key":"4894_CR58","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1111\/j.1365-2141.1958.tb03845.x","volume":"4","author":"IS Bailey","year":"1958","unstructured":"Bailey, I. S. & Prankerd, T. A. Studies in thalassaemia. Br. J. Haematol. 4, 150\u2013155 (1958).","journal-title":"Br. J. Haematol."},{"key":"4894_CR59","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1126\/science.288.5466.669","volume":"288","author":"M Cavazzana-Calvo","year":"2000","unstructured":"Cavazzana-Calvo, M. et al. Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease. Science 288, 669\u2013672 (2000).","journal-title":"Science"},{"key":"4894_CR60","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.1016\/S0140-6736(04)17590-9","volume":"364","author":"HB Gaspar","year":"2004","unstructured":"Gaspar, H. B. et al. Gene therapy of X-linked severe combined immunodeficiency by use of a pseudotyped gammaretroviral vector. Lancet 364, 2181\u20132187 (2004).","journal-title":"Lancet"},{"key":"4894_CR61","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1056\/NEJMoa012616","volume":"346","author":"S Hacein-Bey-Abina","year":"2002","unstructured":"Hacein-Bey-Abina, S. et al. Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapy. N. Engl. J. Med. 346, 1185\u20131193 (2002).","journal-title":"N. Engl. J. Med."},{"key":"4894_CR62","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1002\/(SICI)1097-0029(19971201)39:5<387::AID-JEMT1>3.0.CO;2-E","volume":"39","author":"W Timens","year":"1997","unstructured":"Timens, W. & Kamps, W. A. Hemopoiesis in human fetal and embryonic liver. Microsc. Res. Tech. 39, 387\u2013397 (1997).","journal-title":"Microsc. Res. Tech."},{"key":"4894_CR63","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1083\/jcb.201102131","volume":"195","author":"EM Pietras","year":"2011","unstructured":"Pietras, E. M., Warr, M. R. & Passegue, E. Cell cycle regulation in hematopoietic stem cells. J. Cell Biol. 195, 709\u2013720 (2011).","journal-title":"J. Cell. Biol."},{"key":"4894_CR64","doi-asserted-by":"publisher","first-page":"2388","DOI":"10.1002\/cbic.200800441","volume":"9","author":"V Chenna","year":"2008","unstructured":"Chenna, V. et al. A simple cytosine to G-clamp nucleobase substitution enables chiral gamma-PNAs to invade mixed-sequence double-helical B-form DNA. Chembiochem 9, 2388\u20132391 (2008).","journal-title":"Chembiochem"},{"key":"4894_CR65","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/978-1-4939-0992-6_8","volume":"1176","author":"AS Ricciardi","year":"2014","unstructured":"Ricciardi, A. S., McNeer, N. A., Anandalingam, K. K., Saltzman, W. M. & Glazer, P. M. Targeted genome modification via triple helix formation. Methods Mol. Biol. 1176, 89\u2013106 (2014).","journal-title":"Methods Mol. Biol."},{"key":"4894_CR66","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1093\/bioinformatics\/btt593","volume":"30","author":"J Zhang","year":"2014","unstructured":"Zhang, J., Kobert, K., Flouri, T. & Stamatakis, A. PEAR: a fast and accurate Illumina Paired-End reAd mergeR. Bioinformatics 30, 614\u2013620 (2014).","journal-title":"Bioinformatics"},{"key":"4894_CR67","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1093\/bioinformatics\/btp698","volume":"26","author":"H Li","year":"2010","unstructured":"Li, H. & Durbin, R. Fast and accurate long-read alignment with Burrows-Wheeler transform. Bioinformatics 26, 589\u2013595 (2010).","journal-title":"Bioinformatics"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-018-04894-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-018-04894-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-018-04894-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T15:04:22Z","timestamp":1671548662000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-018-04894-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,26]]},"references-count":67,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["4894"],"URL":"https:\/\/doi.org\/10.1038\/s41467-018-04894-2","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,26]]},"assertion":[{"value":"6 October 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"R.B., P.M.G., E.Q., A.S.R., D.H.S., D.H.L., and W.M.S. are inventors on patent applications describing nanoparticle-mediated delivery of triplex-forming PNAs for gene editing. W.M.S., D.H.S., J.S.F., A.S.R, and A.H.B. are inventors on a patent application for in utero therapies using particles for protein delivery.\u00a0D.H.L. and R.B.\u00a0 are\u00a0inventors on a patent application regarding the synthesis of \u03b3PNAs. These patents have been licensed to Trucode Gene Repair, Inc., San Francisco, CA. P.M.G. and W.M.S. are consultants for and have equity interests in Trucode Gene Repair, Inc. The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2481"}}